News
GlaxoSmithKline und Alphabet-Tochter gründen Gemeinschaftsfirma
GlaxoSmithKline und Alphabet-Tochter gründen Gemeinschaftsfirma
Shire und Baxalta: Der große Tag rückt näher
Form 8.3 - The Vanguard Group, Inc.: NMC Health plc
Form 8.3 - The Vanguard Group, Inc.: NMC Health plc
Form 8.3 - The Vanguard Group, Inc.: NMC Health plc
Form 8.3 - The Vanguard Group, Inc.: NMC Health plc
Form 8.3 - The Vanguard Group, Inc.: NMC Health plc
Form 8.3 - The Vanguard Group, Inc.: NMC Health plc
Form 8.3 - The Vanguard Group, Inc.: NMC Health plc
Form 8.3 - The Vanguard Group, Inc.: NMC Health plc
Form 8.3 - The Vanguard Group, Inc.: NMC Health plc
Form 8.3 - The Vanguard Group, Inc.: NMC Health plc
Form 8.3 - The Vanguard Group, Inc.: NMC Health plc
Amarin Plc (AMRN) Q1 2024 Earnings Call Transcript
Image source: The Motley Fool.
Amarin Plc (NASDAQ: AMRN)Q1 2024 Earnings CallMay 01, 2024, 8:00 a.m. ET
Operator
Source Fool.com
Why Amarin Stock Was Rocketing Higher on Wednesday
Any one-product company that receives good news about that product will likely attract investors. That was the case Wednesday with Amarin (NASDAQ: AMRN), which received very encouraging news about
Is Viatris a Great Dividend Stock or Just a Value Trap?
Viatris (NASDAQ: VTRS) is a large and diverse pharmaceutical business that spun off from Pfizer in 2020. The company's medications are in 165 countries and much of its business centers around
Is Viatris a Great Dividend Stock or Just a Value Trap?
Viatris (NASDAQ: VTRS) is a large and diverse pharmaceutical business that spun off from Pfizer in 2020. The company's medications are in 165 countries and much of its business centers around
Amarin Plc (AMRN) Q4 2023 Earnings Call Transcript
Image source: The Motley Fool.
Amarin Plc (NASDAQ: AMRN)Q4 2023 Earnings CallFeb 29, 2024, 8:00 a.m. ET
Operator
Source Fool.com
Why Amarin Stock Skyrocketed Today
Shares of Amarin (NASDAQ: AMRN) skyrocketed 32.9% on Wednesday after the biopharmaceutical company announced strong preliminary fiscal fourth-quarter results, a new share-repurchase authorization
Amarin Plc (AMRN) Q3 2023 Earnings Call Transcript
Image source: The Motley Fool.
Amarin Plc (NASDAQ: AMRN)Q3 2023 Earnings CallNov 01, 2023, 8:00 a.m. ET
Operator
Source Fool.com
Ozempic Just Shrugged Off a Challenge From Viatris. What Does This Mean for Investors?
As you may have heard, Novo Nordisk (NYSE: NVO) makes Ozempic, the type 2 diabetes medication sweeping the globe and raking in billions in the process. Where there's a money-printing drug in ascent
Ozempic Just Shrugged Off a Challenge From Viatris. What Does This Mean for Investors?
As you may have heard, Novo Nordisk (NYSE: NVO) makes Ozempic, the type 2 diabetes medication sweeping the globe and raking in billions in the process. Where there's a money-printing drug in ascent
Viatris Just Sold Off 3 Key Segments. Is It Still a Buy?
On Oct. 1, Viatris (NASDAQ: VTRS) made an announcement that's sure to shake up its fortunes. It's divesting nearly all of its over-the-counter (OTC) medicines, its entire women's healthcare segment
Viatris Just Sold Off 3 Key Segments. Is It Still a Buy?
On Oct. 1, Viatris (NASDAQ: VTRS) made an announcement that's sure to shake up its fortunes. It's divesting nearly all of its over-the-counter (OTC) medicines, its entire women's healthcare segment